Putative modifier genes in mevalonate kinase deficiency.

Area of Science:

• Genetics
• Immunology
• Biochemistry

Background:

• Mevalonate kinase deficiency (MKD) is an autosomal recessive auto-inflammatory disorder.
• The precise molecular mechanisms and factors influencing MKD's variable clinical presentation are not fully understood.
• Identifying novel regulatory genes may elucidate genotype-phenotype correlations in this orphan disease.

Purpose of the Study:

• To investigate potential genetic modifiers contributing to the phenotype variability in Mevalonate kinase deficiency (MKD).
• To identify novel genes that may predispose or amplify the deregulation of the mevalonate pathway in MKD patients.

Main Methods:

• Whole exome sequencing was performed on DNA samples from five patients diagnosed with MKD.
• Genetic variations were analyzed for potential correlations with observed clinical phenotypes.

Main Results:

• A homozygous missense variation in the PEX11γ gene was identified in one patient, potentially linked to visual blurring.
• A homozygous rare gene variant in UNG was detected in another patient, without a clear clinical correlation.
• Several other variants were found, but no definitive genotype-phenotype correlations were established within this small cohort.

Conclusions:

• Further investigation with larger sample sizes and next-generation sequencing is warranted for MKD.
• Identifying specific modifier genes associated with MVK mutations could lead to earlier diagnosis of MKD.
• Understanding genetic modifiers is crucial for explaining non-homogeneous genotype-phenotype correlations in MKD.